Han-Su Park
Chief Executive Officer chez GENOME & COMPANY
Fortune : 12 M $ au 31/03/2024
Profil
Han-Su Park is the founder of Genome & Co. established in 2015, where he holds the title of Co-CEO, Director & Head-Research.
He is currently a Professor at Gwangju Institute of Science & Technology since 2015.
Dr. Park's former position was as an Independent Director at NKMAX Co., Ltd.
(South Korea).
He obtained his doctorate degree from Seoul National University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENOME & CO.
11,38% | 28/03/2024 | 1 703 380 ( 11,38% ) | 12 M $ | 31/03/2024 |
Postes actifs de Han-Su Park
| Sociétés | Poste | Début |
|---|---|---|
| GENOME & COMPANY | Chief Executive Officer | 24/09/2015 |
| Gwangju Institute of Science & Technology | Corporate Officer/Principal | 01/01/2015 |
Anciens postes connus de Han-Su Park
| Sociétés | Poste | Fin |
|---|---|---|
| NKMAX CO., LTD. | Director/Board Member | - |
Formation de Han-Su Park
| Seoul National University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NKMAX CO., LTD. | Health Technology |
| GENOME & COMPANY | Health Technology |
